These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. CREDO: a protein-ligand interaction database for drug discovery. Schreyer A; Blundell T Chem Biol Drug Des; 2009 Feb; 73(2):157-67. PubMed ID: 19207418 [TBL] [Abstract][Full Text] [Related]
27. Data mining a small molecule drug screening representative subset from NIH PubChem. Xie XQ; Chen JZ J Chem Inf Model; 2008 Mar; 48(3):465-75. PubMed ID: 18302356 [TBL] [Abstract][Full Text] [Related]
28. Quantitative structure-pharmacokinetic/pharmacodynamic relationships. Mager DE Adv Drug Deliv Rev; 2006 Nov; 58(12-13):1326-56. PubMed ID: 17092600 [TBL] [Abstract][Full Text] [Related]
29. Databases and data mining for computational vaccinology. Flower DR Curr Opin Drug Discov Devel; 2003 May; 6(3):396-400. PubMed ID: 12833673 [TBL] [Abstract][Full Text] [Related]
30. A collaborative database and computational models for tuberculosis drug discovery. Ekins S; Bradford J; Dole K; Spektor A; Gregory K; Blondeau D; Hohman M; Bunin BA Mol Biosyst; 2010 May; 6(5):840-51. PubMed ID: 20567770 [TBL] [Abstract][Full Text] [Related]
31. Using computational modeling to drive the development of targeted therapeutics. Nielsen UB; Schoeberl B IDrugs; 2005 Oct; 8(10):822-6. PubMed ID: 16254802 [TBL] [Abstract][Full Text] [Related]
32. Introduction to the mining of clinical data. Harrison JH Clin Lab Med; 2008 Mar; 28(1):1-7, v. PubMed ID: 18194715 [TBL] [Abstract][Full Text] [Related]
33. Computational toxicology in drug development. Muster W; Breidenbach A; Fischer H; Kirchner S; Müller L; Pähler A Drug Discov Today; 2008 Apr; 13(7-8):303-10. PubMed ID: 18405842 [TBL] [Abstract][Full Text] [Related]
34. Competitive Workflow: novel software architecture for automating drug design. Cartmell J; Krstajic D; Leahy DE Curr Opin Drug Discov Devel; 2007 May; 10(3):347-52. PubMed ID: 17554862 [TBL] [Abstract][Full Text] [Related]
35. Importance of molecular computer modeling in anticancer drug development. Geromichalos GD J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268 [TBL] [Abstract][Full Text] [Related]
36. An efficient implementation of a drug candidate database. Ben Miled Z; Liu Y; Powers D; Bukhres O; Bem M; Jones R; Oppelt RJ J Chem Inf Comput Sci; 2003; 43(1):25-35. PubMed ID: 12546534 [TBL] [Abstract][Full Text] [Related]
37. Assessing association rules and decision trees on analysis of diabetes data from the DiabCare program in France. Quentin-Trautvetter J; Devos P; Duhamel A; Beuscart R; Stud Health Technol Inform; 2002; 90():557-61. PubMed ID: 15460755 [TBL] [Abstract][Full Text] [Related]
38. Current status and future direction of the molecular modeling industry. Richon AB Drug Discov Today; 2008 Aug; 13(15-16):665-9. PubMed ID: 18675761 [TBL] [Abstract][Full Text] [Related]
39. Future of toxicology--predictive toxicology: An expanded view of "chemical toxicity". Richard AM Chem Res Toxicol; 2006 Oct; 19(10):1257-62. PubMed ID: 17040094 [TBL] [Abstract][Full Text] [Related]
40. Penalized and weighted K-means for clustering with scattered objects and prior information in high-throughput biological data. Tseng GC Bioinformatics; 2007 Sep; 23(17):2247-55. PubMed ID: 17597097 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]